NEW
YORK, July 25, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law
firm, is investigating whether certain officers and directors of
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) breached their
fiduciary duties to shareholders. The investigation concerns
potential self-dealing. Shareholders may be entitled to
damages and corporate governance reforms.
If you own ZNTL please contact Moon Young by email
at moon@kuehn.law or call (833) 672-0814. The consultation
and case are free with no obligation to you. Kuehn Law pays all case costs and does not
charge its investor clients. Shareholders should contact the
firm immediately as there may be limited time to enforce your
rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved,
you contribute to the integrity and fairness of the financial
markets. Your investment. Your voice. Your future.™
For additional information, please visit Shareholder Derivative
Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-zentalis-pharmaceuticals-inc-to-contact-law-firm-302206787.html
SOURCE Kuehn Law, PLLC